2804, 2016

Study Finds 91% of Opioid Overdose Patients Who Survive Continue to be Prescribed More Opioids

April 28th, 2016|Drug Overdose, Opiates, Painkillers|0 Comments

A new study reveals that most prescription opioid overdose patients who survive the overdose go right on getting more opioids prescribed to them after they recover.

And that’s not all.

A significant number of those patients – as many as one out of every six – suffers another overdose fairly soon.

And there’s more.

Everyone knows, or should know, that a nonfatal opioid overdose offers a perfect opportunity to identify and treat substance abuse disorders. The patient is right there, thankful to be alive and breathing again. The moment to reach out and help, the best time for an intervention, is now.

But it seems that few ever receive an […]

2104, 2016

Kevin Polito Finds a New Life After a Dozen Rehabs

April 21st, 2016|Inspiration, News, Vicodin|0 Comments

(Novus writes inspirational stories of people in the news who have overcome addiction. This is not to infer that these people are connected to Novus Medical Detox Center but simply to provide hope and encouragement to those fighting addiction.)

Kevin Polito openly admits that while he was in college at Duqesne University in Pittsburgh, PA, he was a “functioning addict” – a sort of “dual-personality” person who is fully addicted to drugs or alcohol, but who still manages to get a lot done in life without attracting attention to their addiction.

In fact, Polito says, he maintained a perfect 4.0 Grade Point Average and held a full-time […]

1904, 2016

FDA introduces draft plan for abuse-deterrent generic opioids

April 19th, 2016|Legal, Opiates, OxyContin/Oxycodone|0 Comments

In its second move in a week aimed at beefing up regulations concerning the nation’s opioid addiction epidemic, the Food and Drug Administration (FDA) has introduced guidelines for the development of abuse-deterrent formulations for all approved generic oral prescription opioids.

Earlier in the week, the agency announced it would call for “black-box” label warnings to all immediate-release (IR) opioid painkillers, which include roughly 175 branded and generic drugs. Similar warnings were added to the labels of extended-release (ER) prescription opioids three years ago.

The FDA said the plan supports the industry’s development of abuse-deterrent formulations (ADF) for generic versions of approved opioids while ensuring that generic ADF […]

1204, 2016

Federal commission urges Congress and White House to improve care for newborns suffering drug withdrawal

April 12th, 2016|Addiction, Legal, Opiates|0 Comments

Newborn babies are suffering and dying from drug withdrawal, and Congress and the White House need to strengthen regulations governing their care and protection, says a federal commission studying child neglect and abuse.

The Commission to Eliminate Child Abuse and Neglect Fatalities (CECANF) has released its report after two years of study. It’s clear that in many areas of the country, infants who are born in drug withdrawal, and also their drug-using mothers, are not getting the care they require. As a result, babies are dying and families are suffering.

The Commission was established by law under the new Protect Our Kids Act of 2012, and was […]

704, 2016

States Reach for More Control Over Prescribing of Opioid Painkillers

April 7th, 2016|Legal, News, Opiates, OxyContin/Oxycodone, Vicodin|0 Comments

Tired of waiting for federal action, a number of states are introducing legislation to control the prescribing of opioid painkillers, such as Vicodin, Percocet and OxyContin.

Motivated by the soaring numbers of deaths from overdoses of prescription opioid painkillers and to a lesser extent heroin, state lawmakers are introducing, or at least considering new bills that limit how much opioid doctors in the state can prescribe per patient – how much opioid per pill, how many pills per prescription, and when the drugs can be prescribed at all.

The latest example of such legislation comes from Massachusetts, where a bill has been passed that places severe restrictions […]

504, 2016

FDA finally adds ‘black-box’ warning labels to the most widely-used single-dose painkillers

April 5th, 2016|Legal, Opiates|0 Comments

After years of foot-dragging, the Food and Drug Administration (FDA) has finally decided to call for its most stringent “black box warnings” to be added to the labels of some 175 generic and brand-name opioid immediate-release (IR) prescription painkillers.

The targeted drugs are among the most commonly prescribed drugs in the country and account for 90 percent of all opioid painkillers prescribed. The new labels will include a warning about the risks for misuse, abuse, addiction, overdose and death.

This latest move is part of the federal government’s broad new campaign addressing the country’s epidemic of opioid abuse, addiction and overdose fatalities linked to prescription opioid painkillers […]

3103, 2016

FDA urged to add ‘black-box’ warning labels about deadly risk of mixing opioids with benzodiazepines

March 31st, 2016|Benzodiazepine, Legal, News, Opiates|0 Comments

A few weeks ago we reported about new research showing that combining opioids with benzodiazepines carries a 4-times-higher risk of fatal overdose.

Now we read in the Washington Post that “dozens of public health officials and academics across the country are pushing the Food and Drug Administration (FDA) to warn people about the potential dangers of taking powerful prescription painkillers alongside common anti-anxiety drugs known as benzodiazepines.”

The paper says 41 officials from various state and municipal health departments and universities have submitted a petition to the FDA. They are urging the agency to add “black box warnings” to the labels of all opioids and benzos.

A “black […]

2903, 2016

Will the FDA’s Settlement with a Tiny, One-Drug Company Open the Door to Off-Label Marketing for Big Pharma?

March 29th, 2016|Legal, News|0 Comments

In recent years, numerous Big Pharma companies have been fined hundreds of millions and even billions of dollars for “off-label marketing” – promoting uses for its drugs that have not been ruled “safe and effective” by the FDA.

Restrictions on what drug companies can say to promote their products don’t restrict what physicians can prescribe. Doctors can use FDA approved drugs any way they want to. The issue is only about what manufacturers can say, or not say, to promote their products.
If the FDA’s recent loss in court to a tiny, one-drug company has the snowballing effect many observers expect, it could soon lift the lid […]

2403, 2016

Senate Approves Sweeping New Legislation Shifting Policy Away from Punishment and Towards Treatment

March 24th, 2016|Legal, News, Opiates|0 Comments

The new bill took three years of bipartisan effort, and addresses many aspects of the battle to end the nation’s opioid epidemic. But it may prove to be too little too late because of a serious lack of funding.

In a 94-to-1 vote that shows overwhelming bipartisan support in the war against addiction, the Senate has approved a new bill aimed at shifting federal drug policy away from punishment and more toward treatment and recovery.

Called the Comprehensive Addiction and Recovery Act (CARA) of 2015, the bill was sponsored by Sens. Rob Portman (R-Ohio) and Sheldon Whitehouse (D-RI).

The new legislation was the product of nearly three […]

2203, 2016

Five common prescription drugs that cause memory loss

March 22nd, 2016|Antidepressant, Benzodiazepine, Drugs|0 Comments

Do you want to protect your memory from being wiped out with no warning?

We don’t mean just your bad memories. We mean all your memories – sometimes for a little while, but sometimes forever.

Thanks to reporter John Ericson’s excellent article in Medical Daily, we have learned that five of the most common prescription drugs impair memory – and you’re probably taking one or more of them yourself every day.

In fact, almost everyone in America takes one or more of these drugs at some point in their lives.

These drugs can cause memory loss for an extended period of time. Or they can make it impossible to […]